Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 3
2011 2
2012 2
2013 3
2014 3
2015 2
2016 3
2017 7
2018 10
2019 8
2020 13
2021 12
2022 16
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Symptomatic corpus luteum hemorrhage in adolescent females with ITP.
Yelak A, From A, Gilad O, Brik Simon D, Rubin S, Cohen M, Amarilyo G, Levin C, Bakry D, Izraeli S, Tamary H, Yacobovich J, Steinberg-Shemer O. Yelak A, et al. Among authors: amarilyo g. Eur J Pediatr. 2024 Apr 11. doi: 10.1007/s00431-024-05560-0. Online ahead of print. Eur J Pediatr. 2024. PMID: 38602530
An "On Demand" canakinumab regimen for treating children with Colchicine-Resistant familial Mediterranean fever - A multicentre study.
Shehadeh K, Levinsky Y, Kagan S, Zuabi T, Tal R, Aviran NH, Butbul Aviel Y, Tirosh I, Spielman S, Miller-Barmak A, Semo Oz R, Harel L, Chodick G, Amarilyo G. Shehadeh K, et al. Among authors: amarilyo g. Int Immunopharmacol. 2024 May 10;132:111967. doi: 10.1016/j.intimp.2024.111967. Epub 2024 Apr 3. Int Immunopharmacol. 2024. PMID: 38569431
Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non-Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular-Course Juvenile Idiopathic Arthritis.
Mannion ML, Amin S, Balevic S, Chang ML, Correll CK, Kearsley-Fleet L, Hyrich KL, Beukelman T; Childhood Arthritis and Rheumatology Research Alliance Registry Investigators and the UK Juvenile Idiopathic Arthritis Biologics Register Investigators. Mannion ML, et al. Arthritis Care Res (Hoboken). 2024 Mar 31. doi: 10.1002/acr.25339. Online ahead of print. Arthritis Care Res (Hoboken). 2024. PMID: 38556945
Body mass index and migraine in adolescence: A nationwide study.
Zloof Y, Tsur AM, Simchoni M, Derazne E, Tzur D, Honig A, Braun M, Ganelin-Cohen E, Amarilyo G, Pinhas-Hamiel O, Afek A, Twig G. Zloof Y, et al. Among authors: amarilyo g. Cephalalgia. 2023 Oct;43(10):3331024231209309. doi: 10.1177/03331024231209309. Cephalalgia. 2023. PMID: 37882650 Free article.
Loss of function of ENT3 drives histiocytosis and inflammation through TLR-MAPK signaling.
Shiloh R, Lubin R, David O, Geron I, Okon E, Hazan I, Zaliova M, Amarilyo G, Birger Y, Borovitz Y, Brik D, Broides A, Cohen-Kedar S, Harel L, Kristal E, Kozlova D, Ling G, Shapira Rootman M, Shefer Averbuch N, Spielman S, Trka J, Izraeli S, Yona S, Elitzur S. Shiloh R, et al. Among authors: amarilyo g. Blood. 2023 Nov 16;142(20):1740-1751. doi: 10.1182/blood.2023020714. Blood. 2023. PMID: 37738562
Discovery of a Novel Missense Variant in NLRP3 Causing Atypical Cryopyrin-Associated Periodic Syndromes With Hearing Loss as the Primary Presentation, Responsive to Anti-Interleukin-1 Therapy.
Birk-Bachar M, Cohen H, Sofrin-Drucker E, Kropach-Gilad N, Orenstein N, Lidzbarsky G, Kornreich L, Tal R, Amarilyo G, Levinsky Y, Sokolov M, Raveh E, Gerlic M, Harel L. Birk-Bachar M, et al. Among authors: amarilyo g. Arthritis Rheumatol. 2024 Mar;76(3):444-454. doi: 10.1002/art.42721. Epub 2024 Jan 9. Arthritis Rheumatol. 2024. PMID: 37738164
92 results